Premium
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s produ... Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of products to address therapeutic areas with unmet medical need. Its proprietary Diffusphere technology optimizes drug delivery for applications with significant unmet medical need. The company’s product portfolio includes EP-104IAR, which is in Phase III clinical trial for the treatment of knee osteoarthritis; EP-104GI that is in Phase II clinical trial for treating eosinophilic esophagitis; and EP-104, which is under preclinical studies for the treatment of gastrointestinal tract, such as eosinophilic esophagitis. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012. Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.91 | -18.65234375 | 10.24 | 10.24 | 8.29 | 98308 | 9.19078427 | CS |
| 4 | -1.9 | -18.5728250244 | 10.23 | 10.77 | 8.29 | 63411 | 9.53587053 | CS |
| 12 | -2 | -19.3610842207 | 10.33 | 11.04 | 8.29 | 57627 | 9.81654706 | CS |
| 26 | 0.09 | 1.09223300971 | 8.24 | 12.86 | 8.15 | 75519 | 10.59921113 | CS |
| 52 | 2.93 | 54.2592592593 | 5.4 | 12.86 | 5.2 | 60890 | 9.57155093 | CS |
| 156 | 1.35 | 19.340974212 | 6.98 | 12.86 | 3.07 | 41580 | 7.35519398 | CS |
| 260 | 3.93 | 89.3181818182 | 4.4 | 12.86 | 0.8 | 33118 | 6.24139399 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
